CompletedPhase 4

Effects of General Anesthesia and Spinal-Morphine Anesthesia on Recovery and Comfort After Benign Abdominal Hysterectomy

Sweden180 participantsStarted 2007-03

Plain-language summary

The purpose of this study is to determine whether spinal anesthesia combined with intrathecal morphine in abdominal hysterectomy on benign gynecological indications gives better outcome concerning duration of hospital stay and postoperative patient comfort than general anesthesia.

Who can participate

Age range

18 Years – 60 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female between 18 and 60 years of age. * Scheduled for abdominal hysterectomy - total or subtotal -on benign gynecological indication. * At least one ovary planned to be preserved at the hysterectomy. * Can understand and communicate in Swedish * Accept participation after written and verbal information and after signed informed consent. * Has supervision at home after discharge from hospital during the first couple of days and has access to a telephone. Exclusion Criteria: * Contra-indications against spinal or general anesthesia or the standard dosage of the study drugs * ASA classification ≥ Class 3 * Postmenopausal women without HRT (hormone replacement therapy). * Suspected gynecological malignancy * Previously undergone bilateral oophorectomy * Substantial physically disabled so that a normal recovery with early physical mobilization can not be anticipated. * Mentally or severly psychic disabled

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Duration of Hospital Stay.

Timeframe: Within 6 months after surgery

Trial details

NCT IDNCT00527332

SponsorPreben Kjolhede

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-06

Results submitted2011-11-14

View on ClinicalTrials.gov More Hysterectomy (MeSH nr: E04.950.300.399) trials